θÖ×Áö/ÖÎÁÆ,Stomach neoplasms/therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎѪ¹ÜÈâÁö,Hepatic angiosarcomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±Çµ¨¹Ü,Nasobiliary ductÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½»½çÐÔ²¡±ä,borderline lesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤¶ñÐÔ¼äÆ¤Áö,Malignant peritoneal mesotheliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʵÐÔ-¼ÙÈéÍ·×´Ö×Áö,solid-pseudopapillary tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ç»³åÏ´Òº,Peritoneal washesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Gli1µ°°×,Gli1 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ç»Éñ¾´Ô×èÖÍ,neurolytic celiac plexus blockÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦ÏÙÁö,Rectal adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñ×ÐÔ¼¡ÏËάĸϸ°ûÖ×Áö,Inflammatory myofibroblastic tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕûºÏËØ¦Áv,integrin ¦ÁvÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
cyclinD1µ°°×ÖÊ,cyclinD1 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡ÀíÑ§ÌØµã,pathological characteristicÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±µ¼ÁÔìÓ°,barium mealÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼õÁöÊõ,cytoreductive surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Åöײ°©,Collision carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²ºÍ²¡Àí,Clinic and pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍíÆÚêÚÃŰ©,advanced cardiac carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÔà×ªÒÆÁö,liver metastasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙµ¼¹ÜÏÙ°©,Pancreatic ductal adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¹¦ÄÜʧ´ú³¥,liver function discompensationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
U¹Ü,U tubeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇøÓòÐÔÒÈÏÙÇгýÊõ,regional pancreatectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôç·¢ÏÖ,early detectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÝÐýË®µ¶,Helix hydro-jetÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¸Âö³åµç³¡,steep pulsed electric field(SPEF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦Ö×Áö/ÖÎÁÆ,gastrointestinal neoplasms/therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔθ¶ñÐÔÁܰÍÁö,Primary gastric malignant lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ°©Ö×Áö,stomach neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºôÎü¶¯¶È,Breathing movementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊõÖб£ÎÂ,Intraoperative warmingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
H22¸Î°©ÒÆÖ²Áö,murine hepatoma H22 liver cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÌÎå¼ÓÔíß°,Acanthopanax senticousus saponinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Æ¼¤ËØÊÜÌå2,estrogen receptor 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÆËã»úÌå²ã³ÉÏñ(CT),Computed tomography(CT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÒÖÖÆµ°°×Àà,Tumor Suppressor ProteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ°°×µÄ±í´ï,protein expressionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MHCC97-Hϸ°û,MHCC97-H cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ùÒò×é²»Îȶ¨,genomic instabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÖÜÉÏÆ¤Ñùϸ°ûÁö,Perivascular epithelioid cell tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ¼²²¡/Íâ¿ÆÊÖÊõ,stomach diseases/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦ÏµÄ¤ÉϾ²Âö/Íâ¿ÆÑ§,Superior Mesentery Vein/surgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØ¸¹ÁªºÏÇпÚ,thoracoabdominal incisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö÷¶¯ºôÎü¿ØÖƼ¼Êõ,Active breathing controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ²¡Éú´æÆÚ,disease-free survivalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Âö»¯ÁÆË¨ÈûÊõ,transcatheter arterial chemoembolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
VX2¸Î°©,VX_2 Liver tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˫Է¢°©,multiple primary cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²×ªÒÆ,ovarian metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
СÊó¸Î°©H22,Murine Hepatoma 22Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÖÂþÐÍθ°©,diffuse-type gastric carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¢Ì嶨ÏòÕÕÉä,stereotactic irradiationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²à²àÎǺÏ,side-to-side neurorrhaphyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
cdc25Á×Ëáø,cdc25 phosphataseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙ°©Ï¸°û,Pancreatic cancer cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±£Áô¸ØÃÅ,sphincter preservationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
3ÖÜ·½°¸,3-week regimenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CD147µ°°×,CD147 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈÐݿ˵°°×90ÒÖÖÆ¼Á,heat shock protein 90 inhibitorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±¶Îʳ¹Ü°©,Cervical esophageal carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ(³¦)ÑÊÎǺÏÊõ,Gastric(enteric)-pharyngeal anastomosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÅÝϸ°û°©,acinar cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤ºóÉñ¾ÇÊÁö,retroperitoneal schwannomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TIMP3»ùÒò,TIMP3 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MMP-2mRNA,MMP-2 mRNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßΣģÐÍ,High risk modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÈ¼ÁÁ¿ÇúÏß,Isodose CurveÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àà°©Áö/Íâ¿ÆÑ§,carcinoid tumor/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎβҶ,caudate lobeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÅÐÔÄÉÃ×΢Á£,Magnetic nanoparticlesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅèÇ»×ÔÖ÷Éñ¾±£Áô,Pelvic autonomic nerve preservationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ÂɳÀû²¬/ÖÎÁÆÓ¦ÓÃ,Oxaliplatin/therapeutic useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎïѧÖá,Biological axisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢²¨µ¶,Microwave KnifeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÑùÉú³¤Òò×Ó¢ñÊÜÌå,Insulin-like growth factor-¢ñ receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Wnt/¦Â-cateninͨ·,Wnt/¦Â-catenin pathwayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î÷»Æ½ºÄÒ,Xihuang capsulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äÖÊÁö/Õï¶Ï,Stromal Tumor/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äÖÊÁö/Íâ¿ÆÑ§,Stromal Tumor/surgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GGT»ùÒò,GGT geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ת»¯Éú³¤Òò×Ó¦Â/ѪҺ,Transforming growth factor beta/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÀà°©,gastric carcinoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯Âö²å¹Ü»¯ÁÆË¨Èû,Transcatheter arterial chemoembolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Èë׸ÊëÄ-S-×ªÒÆÃ¸¦Ð,glutathione-S-transferase ¦ÐÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êõºó¾Ö²¿¸´·¢,Postoperate local recurrenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËθ°©,Human gastric carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÁöÐÔÏ¢Èⲡ,adenomatous polyposisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³öÉú˳Ðò·ÖÎö,birth order analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÃVX2,rabbit VX_2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¢Ë¾Æ¥ÁÖ-ÑÌõ£°·-пÂçºÏÎï,aspirin-niacinamide-zinc complexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¤³Ìϸ°ûÖê,Engineering cell lineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Å´ó³¦¾µ,Magnifying colonoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Æ¼¤ËØÊÜÌåÏà¹ØÊÜÌå,Estrogen receptor-related receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²Ö×Áö/¼Ì·¢ÐÔ,ovarian neoplasms/secondaryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÅòʽ´øÄ¤Ö§¼Ü,Self-expanding covered stentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔ¸Îϸ°ûÐԸΰ©,primary hepatocellular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤ºóÖ×Áö/Õï¶Ï,retroperitoneal neoplasms/DIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÐÂÉúѪ¹ÜÉú³É,tumor angiogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹Ö×ÁöÒ©(ÖÐÒ©)/Ò©Àíѧ,antineoplastic drugs (TCD)/pharmacologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|